CARCINOMA, SQUAMOUS CELL
Clinical trials for CARCINOMA, SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New enzyme shot takes aim at Hard-to-Treat tumors
Disease control Recruiting nowThis trial tests a new drug called N17350, a modified enzyme injected directly into tumors, in adults with advanced solid tumors that have not responded to standard treatments. The study aims to find the safest and most effective dose, and to see if the drug can shrink or stop tu…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE1, PHASE2 • Sponsor: Onchilles Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Nanoparticles boost radiation to fight head and neck cancer in elderly
Disease control Recruiting nowThis phase 3 trial tests whether injecting NBTXR3 nanoparticles into tumors before radiation therapy can improve outcomes for elderly patients with advanced head and neck cancer who cannot receive chemotherapy. About 500 participants will be randomly assigned to receive either ra…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE3 • Sponsor: Johnson & Johnson Enterprise Innovation Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a simple injection treat leg skin cancer?
Disease control Recruiting nowThis early-stage trial tests injecting a chemotherapy drug (5FU) directly into skin cancers on the lower legs, with or without a vitamin D-based cream (calcipotriene). The goal is to see if the treatment is safe and can shrink tumors. About 30 adults with small squamous cell carc…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE1 • Sponsor: Melissa Pugliano-Mauro • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo shows promise for Tough-to-Treat anal cancer
Disease control Recruiting nowThis study tests whether combining two drugs, lenvatinib and pembrolizumab, can shrink or control advanced anal or rectal cancer that has spread and stopped responding to standard chemotherapy. About 35 adults with this type of cancer will receive the drug combination. The goal i…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New cocktail of cancer drugs targets Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis early-stage trial is testing a new three-drug combination for people with head and neck cancer that has come back or spread. The drugs include a targeted therapy (zanzalintinib), an immunotherapy (pembrolizumab), and another targeted antibody (cetuximab). The main goal is to…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New study aims to spare oral cancer patients from unnecessary neck surgery
Knowledge-focused Recruiting nowThis study looks at whether a feature called tumor budding can help doctors decide if early-stage oral cancer patients need neck lymph node removal. About 524 participants will be randomly assigned to either have the main tumor removed alone or also have neck dissection. The goal…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: NA • Sponsor: Jinsong Hou • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Blood test may predict throat cancer comeback
Knowledge-focused Recruiting nowThis study looks at 220 people with HPV-related oropharynx cancer to see if certain gene mutations (TRAF3 and CYLD) and levels of HPV DNA in the blood can predict if the cancer will come back after treatment. Participants give blood samples and fill out quality-of-life questionna…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Blood test could predict cancer return after surgery
Knowledge-focused Recruiting nowThis study looks at a blood test that measures tiny bits of tumor DNA floating in the blood. Researchers will enroll 50 adults with head and neck cancer who are planning surgery. They want to see how these DNA levels change after surgery and whether they can help predict if the c…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC